Calliditas Therapeutics A...

NASDAQ: CALT · Real-Time Price · USD
40.00
-0.04 (-0.10%)
At close: Sep 20, 2024, 10:00 PM

Calliditas Therapeutics AB (publ) Balance Sheet Statement

Financials in SEK. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
973.73M 1.25B 955.51M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
24.2M 11.21M 3.92M
Other Long-Term Assets
n/a n/a n/a
Receivables
188.19M 80.99M n/a
Inventory
20.43M 3.65M 889K
Other Current Assets
15.78M 10.02M 11.34M
Total Current Assets
1.28B 1.41B 1.01B
Property-Plant & Equipment
54.24M 31.92M 39.61M
Goodwill & Intangibles
479.34M 483.84M 399.42M
Total Long-Term Assets
625.4M 540.77M 447.14M
Total Assets
1.9B 1.95B 1.46B
Account Payables
100.56M 160.4M 67.97M
Deferred Revenue
6.17M 136.45M 3.39M
Short-Term Debt
12.54M n/a n/a
Other Current Liabilities
18.51M 31.01M 18.81M
Total Current Liabilities
407.14M 325.23M 135.45M
Long-Term Debt
939.51M 713.03M 189.16M
Other Long-Term Liabilities
150.36M 92.91M 72.11M
Total Long-Term Liabilities
1.16B 861.48M 316.18M
Total Liabilities
1.57B 1.19B 451.63M
Total Debt
979.13M 728.82M 213.22M
Common Stock
2.38M 2.38M 2.09M
Retained Earnings
-2.31B -1.83B -1.45B
Comprehensive Income
-5.23M 9.31M -26.98M
Shareholders Equity
334.81M 766.26M 1.01B
Total Investments
24.2M 11.21M 3.92M